Baltimore, Maryland
United States
236
2026-06-04
The entities that hold a legal rights for patent applications filed by inventor VOGELSTEIN Bert:
Bert VOGELSTEIN from Baltimore, US has applied for patents for these inventions. The list has both pending applications and granted patents:
METHODS AND MATERIALS FOR ASSESSING NUCLEIC ACIDS
#2 | 2026-05-21SAFE SEQUENCING SYSTEM
#3 | 2026-03-12METHODS FOR IDENTIFYING CNS CANCER IN A SUBJECT
#4 | 2026-03-05CONSENSUS CODING SEQUENCES OF HUMAN BREAST AND COLORECTAL CANCER
#5 | 2026-01-01PERSONALIZED TUMOR BIOMARKERS
#6 | 2026-01-01C. NOVYI FOR THE TREATMENT OF SOLID TUMORS IN NON-HUMAN ANIMALS
#7 | 2025-12-25METHODS FOR SEQUENCING AN IMMUNE CELL RECEPTOR
#8 | 2025-12-18USE OF BACTERIA, BACTERIAL PRODUCTS, AND OTHER IMMUNOREGULATORY ENTITIES IN COMBINATION WITH ANTI-CTLA-4 AND/OR ANTI-PD-1 ANTIBODIES TO TREAT SOLID TUMOR MALIGNANCIES
#9 | 2025-11-27BOTTLENECK SEQUENCING
#10 | 2025-10-23METHODS FOR IDENTIFYING CANCER IN A SUBJECT
#11 | 2025-10-09CIRCULATING MUTANT DNA TO ASSESS TUMOR DYNAMICS
#12 | 2025-06-19HEAD AND NECK SQUAMOUS CELL CARCINOMA ASSAYS
#13 | 2025-05-29SAFE SEQUENCING SYSTEM
#14 | 2025-02-27METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER
#15 | 2025-01-30MANABODIES TARGETING P53 TUMOR ANTIGENS AND METHODS OF USING
#16 | 2025-01-23DETECTION OF TUMOR-DERIVED DNA IN CEREBROSPINAL FLUID
#17 | 2025-01-16METHODS AND MATERIALS FOR ASSESSING NUCLEIC ACIDS
#18 | 2025-01-02RAPID ANEUPLOIDY DETECTION
#19 | 2024-11-28GENETIC ALTERATIONS IN ISOCITRATE DEHYDROGENASE AND OTHER GENES IN MALIGNANT GLIOMA
#20 | 2024-10-24METHODS FOR SIMULTANEOUS MUTATION DETECTION AND METHYLATION ANALYSIS
#21 | 2024-10-17METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER
#22 | 2024-10-17CONSENSUS CODING SEQUENCES OF HUMAN BREAST AND COLORECTAL CANCER
#23 | 2024-09-19SAFE SEQUENCING SYSTEM
#24 | 2024-09-05MANAbodies AND METHODS OF USING
#25 | 2024-08-08SAFE SEQUENCING SYSTEM
#26 | 2024-05-23HLA-RESTRICTED EPITOPES ENCODED BY SOMATICALLY MUTATED GENES
#27 | 2024-05-23METHODS AND MATERIALS FOR TARGETING TUMOR ANTIGENS
#28 | 2024-05-09ENGINEERED IMMUNE CELLS AND USES THEREOF
#29 | 2024-04-18METHODS AND MATERIALS FOR TREATING CLONAL T CELL EXPANSIONS
#30 | 2024-03-28Safe sequencing system
#31 | 2024-03-14Safe sequencing system
#32 | 2024-02-29METHODS OF DETECTING HIGH RISK BARRETT'S ESOPHAGUS WITH DYSPLASIA, AND ESOPHAGEAL ADENOCARCINOMA
#33 | 2024-02-08SIGNAL
#34 | 2024-01-04CIRCULATING MUTANT DNA TO ASSESS TUMOR DYNAMICS
#35 | 2024-01-04METHODS AND MATERIALS FOR TREATING T CELL CANCERS
#36 | 2023-11-16CHECKPOINT BLOCKADE AND MICROSATELLITE INSTABILITY
#37 | 2023-10-26Encapsulated Agents that Bind to MCT-1
#38 | 2023-10-05PREVENTING CYTOKINE RELEASE SYNDROME
#39 | 2023-08-10PAPANICOLAOU TEST FOR OVARIAN AND ENDOMETRIAL CANCERS
#40 | 2023-02-16MANAbodies TARGETING TUMOR ANTIGENS AND METHODS OF USING
#41 | 2023-01-26Checkpoint blockade and microsatellite instability
#42 | 2022-12-01C. NOVYI FOR THE TREATMENT OF SOLID TUMORS IN HUMANS
#43 | 2022-10-06Safe sequencing system
#44 | 2022-09-01Checkpoint blockade and microsatellite instability
#45 | 2022-08-18RAPID ANEUPLOIDY DETECTION
#46 | 2022-08-18Checkpoint blockade and microsatellite instability
#47 | 2022-07-14Head and neck squamous cell carcinoma assays
#48 | 2022-06-30ASSAYING OVARIAN CYST FLUID
#49 | 2022-03-10METHODS AND MATERIALS FOR ASSESSING NUCLEIC ACIDS
#50 | 2022-02-24Checkpoint blockade and microsatellite instability
#51 | 2022-01-13Rapid aneuploidy detection
#52 | 2021-12-23Checkpoint blockade and microsatellite instability
#53 | 2021-10-21Checkpoint blockade and microsatellite instability
#54 | 2021-10-21Checkpoint blockade and microsatellite instability
#55 | 2021-10-14GENETIC ALTERATIONS IN ISOCITRATE DEHYDROGENASE AND OTHER GENES IN MALIGNANT GLIOMA
#56 | 2021-09-09Safe sequencing system
#57 | 2021-09-09SAFE SEQUENCING SYSTEM
#58 | 2021-08-19Safe sequencing system
#59 | 2021-06-10PERSONALIZED TUMOR BIOMARKERS
#60 | 2021-05-27Checkpoint blockade and microsatellite instability
#61 | 2021-05-06TERT promoter mutations in urothelial neoplasia
#62 | 2021-05-06STRAND-SPECIFIC DETECTION OF BISULFITE-CONVERTED DUPLEXES
#63 | 2021-05-06Checkpoint blockade and microsatellite instability
#64 | 2021-04-15Checkpoint blockade and microsatellite instability
#65 | 2021-04-08AUTOIMMUNE ANTIGENS AND CANCER
#66 | 2021-03-04METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER
#67 | 2021-02-25SUPPRESSION OF MYELOID DERIVED SUPPRESSOR CELLS AND IMMUNE CHECKPOINT BLOCKADE
#68 | 2021-01-07Methods of treating liver fibrosis by administering 3-bromopyruvate
#69 | 2020-12-24promoter mutations in gliomas and a subset of tumors
#70 | 2020-12-03Methods and materials for assessing and treating cancer
#71 | 2020-11-26CIRCULATING MUTANT DNA TO ASSESS TUMOR DYNAMICS
#72 | 2020-11-26Preventing cytokine release syndrome
#73 | 2020-10-22C. novyi for the treatment of solid tumors in humans
#74 | 2020-08-06Mutations of the PIK3CA gene in human cancers
#75 | 2020-07-30Consensus coding sequences of human breast and colorectal cancers
#76 | 2020-07-30PROTEIN BIOCONJUGATION METHOD
#77 | 2020-04-23Methods for beaming
#78 | 2020-03-12MANAbodies and methods of using
#79 | 2020-02-13Consensus Coding Sequences of Human Breast and Colorectal Cancers
#80 | 2020-01-23Treatment of cancers having mutations of the PIK3CA gene
#81 | 2019-12-12Safe sequencing system
#82 | 2019-10-31CYCLODEXTRIN COMPOSITIONS ENCAPSULATING A SELECTIVE ATP INHIBITOR AND USES THEREOF
#83 | 2019-10-31LIPOSOME COMPOSITIONS ENCAPSULATING MODIFIED CYCLODEXTRIN COMPLEXES AND USES THEREOF
#84 | 2019-10-03BOTTLENECK SEQUENCING
#85 | 2019-08-22METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER
#86 | 2019-08-22Differential Identification of Pancreatic Cysts
#87 | 2019-08-08COMPOSITIONS AND METHODS FOR IDENTIFYING FUNCTIONAL ANTI-TUMOR T CELL RESPONSES
#88 | 2019-04-11Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma
#89 | 2019-02-21GENES FREQUENTLY ALTERED IN PANCREATIC NEUROENDOCRINE TUMORS
#90 | 2019-01-24Checkpoint blockade and microsatellite instability
#91 | 2019-01-03Detection of tumor-derived DNA in cerebrospinal fluid
#92 | 2018-11-22Somatic mutations in ATRX in brain cancer
#93 | 2018-11-15ARID1A AND PPP2R1A MUTATIONS IN CANCER
#94 | 2018-11-15DIGITAL AMPLIFICATION
#95 | 2018-11-15Methods of treating liver fibrosis by administering 3-bromopyruvate
#96 | 2018-10-04Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma
#97 | 2018-09-13Assaying ovarian cyst fluid
#98 | 2018-07-12Oligodendroglioma drive genes
#99 | 2018-06-21Head and neck squamous cell carcinoma assays
#100 | 2018-06-14Liposome Compositions Encapsulating Modified Cyclodextrin Complexes and Uses Thereof
80169 ⎘